Targeting the RNA helicase DDX6 in acute myeloid leukemia

$767.6K USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Baylor College of Medicine
Country	United States
Start Date	Apr 01, 2024
End Date	Mar 31, 2025
Duration	364 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10826819`

Grant Description

PROJECT SUMMARY Acute myeloid leukemia (AML) is an aggressive blood cancer characterized by the accumulation of abnormal myeloid progenitors arrested in differentiation. It is the most common form of leukemia among adults and the second most common among children. Despite considerable advances in our understanding of this disease,

prognosis for AML patients remains dismal, with five-year survival rates languishing at